{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:09:51Z","timestamp":1789898991571,"version":"4.0.1"},"reference-count":46,"publisher":"Japan Society for Clinical Immunology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn.J.clin.Immun","Jpn. J. Clin. Immunol."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2177\/jsci.38.26","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T22:07:54Z","timestamp":1425938874000},"page":"26-36","source":"Crossref","is-referenced-by-count":23,"title":["The role of podocyte injury in chronic kidney disease"],"prefix":"10.2177","volume":"38","author":[{"given":"Katsuhiko","family":"ASANUMA","sequence":"first","affiliation":[{"name":"Kyoto University Graduate School of Medicine, TMK project, Medical Innovation Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"972","reference":[{"key":"1","unstructured":"1) Mundel, P., Kriz, W.: Structure and function of podocytes: an update. <i>Anat Embryol (Berl)<\/i>. <b>192<\/b>: 385-397, 1995."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Asanuma, K., Mundel, P.: The role of podocytes in glomerular pathobiology. <i>Clin Exp Nephrol<\/i>. <b>7<\/b>: 255-259, 2003.","DOI":"10.1007\/s10157-003-0259-6"},{"key":"3","unstructured":"3) Faul, C., et al.: Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. <i>Trends Cell Biol<\/i>. <b>17<\/b>: 428-437, 2007."},{"key":"4","unstructured":"4) Asanuma, K., et al.: The role of podocytes in proteinuria. <i>Nephrology (Carlton)<\/i>. <b>12<\/b>: S15-20, 2007."},{"key":"5","unstructured":"5) Lehtonen, S., et al.: Cell junction-associated proteins IQGAP1, MAGI-2, CASK, spectrins, and alpha-actinin are components of the nephrin multiprotein complex. <i>Proc Natl Acad Sci U S A<\/i>. <b>102<\/b>: 9814-9819, 2005."},{"key":"6","unstructured":"6) Ihara, K., et al.: MAGI-2 is critical for the formation and maintenance of the glomerular filtration barrier in mouse kidney. <i>Am J Pathol<\/i>. <b>184<\/b>: 2699-2708, 2014."},{"key":"7","unstructured":"7) Asanuma, K., et al.: Dendrin location in podocytes is associated with disease progression in animal and human glomerulopathy. <i>Am J Nephrol<\/i>. <b>33<\/b>: 537-549, 2011."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kriz, W., Lemley, K.V.: A Potential Role for Mechanical Forces in the Detachment of Podocytes and the Progression of CKD. <i>J Am Soc Nephrol<\/i>. 2014.","DOI":"10.1681\/ASN.2014030278"},{"key":"9","unstructured":"9) Kriz, W., et al.: Progression of glomerular diseases: is the podocyte the culprit? <i>Kidney Int<\/i>. <b>54<\/b>: 687-697, 1998."},{"key":"10","unstructured":"10) Suzuki, T., et al.: Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular\/collapsing focal segmental glomerulosclerosis. <i>Am J Pathol<\/i>. <b>174<\/b>: 1675-1682, 2009."},{"key":"11","unstructured":"11) Matsusaka, T., et al.: Podocyte injury damages other podocytes. <i>J Am Soc Nephrol<\/i>. <b>22<\/b>: 1275-1285, 2011."},{"key":"12","unstructured":"12) Asanuma, K., et al.: Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytes. <i>Proc Natl Acad Sci U S A<\/i>. <b>104<\/b>: 10134-10139, 2007."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Shankland, S.J.: The podocyte&apos;s response to injury: role in proteinuria and glomerulosclerosis. <i>Kidney Int<\/i>. <b>69<\/b>: 2131-2147, 2006.","DOI":"10.1038\/sj.ki.5000410"},{"key":"14","unstructured":"14) Shih, N.Y., et al.: CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain. <i>Am J Pathol<\/i>. <b>159<\/b>: 2303-2308, 2001."},{"key":"15","unstructured":"15) Huber, T.B., et al.: Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. <i>Mol Cell Biol<\/i>. <b>23<\/b>: 4917-4928, 2003."},{"key":"16","unstructured":"16) Schiffer, M., et al.: A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-beta-induced apoptosis. <i>J Biol Chem<\/i>. <b>279<\/b>: 37004-37012, 2004."},{"key":"17","unstructured":"17) Yaddanapudi, S., et al.: CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival. <i>J Clin Invest<\/i>. <b>121<\/b>: 3965-3980, 2011."},{"key":"18","unstructured":"18) Campbell, K.N., et al.: Yes-associated protein (YAP) promotes cell survival by inhibiting proapoptotic dendrin signaling. <i>J Biol Chem<\/i>. <b>288<\/b>: 17057-17062, 2013."},{"key":"19","unstructured":"19) Kawata, A., et al.: CIN85 is localized at synapses and forms a complex with S-SCAM via dendrin. <i>J Biochem<\/i>. <b>139<\/b>: 931-939, 2006."},{"key":"20","unstructured":"20) Kodama, F., et al.: Translocation of dendrin to the podocyte nucleus in acute glomerular injury in patients with IgA nephropathy. <i>Nephrol Dial Transplant<\/i>. <b>28<\/b>: 1762-1772, 2013."},{"key":"21","unstructured":"21) Hara, M., et al.: Urinary podocytes in primary focal segmental glomerulosclerosis. <i>Nephron<\/i>. <b>89<\/b>: 342-347, 2001."},{"key":"22","unstructured":"22) Hara, M., et al.: Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis. <i>Am J Nephrol<\/i>. <b>18<\/b>: 35-41, 1998."},{"key":"23","unstructured":"23) Jefferson, J.A., et al.: Podocyte biology for the bedside. <i>Am J Kidney Dis<\/i>. <b>58<\/b>: 835-845, 2011."},{"key":"24","unstructured":"24) Asao, R., et al.: Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy. <i>Clin J Am Soc Nephrol<\/i>. <b>7<\/b>: 1385-1393, 2012."},{"key":"25","unstructured":"25) Hara, M., et al.: Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury. <i>J Am Soc Nephrol<\/i>. <b>16<\/b>: 408-416, 2005."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Nielsen, J.S., McNagny, K.M.: The role of podocalyxin in health and disease. <i>J Am Soc Nephrol<\/i>. <b>20<\/b>: 1669-1676, 2009.","DOI":"10.1681\/ASN.2008070782"},{"key":"27","unstructured":"27) Hara, M., et al.: Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli. <i>Hum Pathol<\/i>. <b>41<\/b>: 1265-1275, 2010."},{"key":"28","unstructured":"28) Kanno, K., et al.: Urinary sediment podocalyxin in children with glomerular diseases. <i>Nephron Clin Pract<\/i>. <b>95<\/b>: c91-99, 2003."},{"key":"29","unstructured":"29) Hara, M., et al.: Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin. <i>Diabetologia<\/i>. <b>55<\/b>: 2913-2919, 2012."},{"key":"30","unstructured":"30) Bao, H., et al.: Successful treatment of class V+IV lupus nephritis with multitarget therapy. <i>J Am Soc Nephrol<\/i>. <b>19<\/b>: 2001-2010, 2008."},{"key":"31","unstructured":"31) Iijima, K., et al.: Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. <i>Lancet<\/i>. <b>384<\/b>: 1273-1281, 2014."},{"key":"32","unstructured":"32) Shalhoub, R.J.: Pathogenesis of lipoid nephrosis: a disorder of T-cell function. <i>Lancet<\/i>. <b>2<\/b>: 556-560, 1974."},{"key":"33","unstructured":"33) Fornoni, A., et al.: Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. <i>Sci Transl Med<\/i>. <b>3<\/b>: 85ra46, 2011."},{"key":"34","unstructured":"34) Wofsy, D., et al.: Abatacept for lupus nephritis: alternative definitions of complete response support conflicting conclusions. <i>Arthritis Rheum<\/i>. <b>64<\/b>: 3660-3665, 2012."},{"key":"35","unstructured":"35) Reiser, J., et al.: Induction of B7-1 in podocytes is associated with nephrotic syndrome. <i>J Clin Invest<\/i>. <b>113<\/b>: 1390-1397, 2004."},{"key":"36","unstructured":"36) Yu, C.C., et al.: Abatacept in B7-1-positive proteinuric kidney disease. <i>N Engl J Med<\/i>. <b>369<\/b>: 2416-2423, 2013."},{"key":"37","unstructured":"37) Lydia, A., et al.: Effects of 22-oxa-calcitriol on podocyte injury in adriamycin-induced nephrosis. <i>Am J Nephrol<\/i>. <b>35<\/b>: 58-68, 2012."},{"key":"38","unstructured":"38) Stumpf, W.E., et al.: Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. <i>Science<\/i>. <b>206<\/b>: 1188-1190, 1979."},{"key":"39","unstructured":"39) Artavanis-Tsakonas, S., et al.: Notch signaling: cell fate control and signal integration in development. <i>Science<\/i>. <b>284<\/b>: 770-776, 1999."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Schweisguth, F.: Regulation of notch signaling activity. <i>Curr Biol<\/i>. <b>14<\/b>: R129-138, 2004.","DOI":"10.1016\/j.cub.2004.01.023"},{"key":"41","unstructured":"41) Chen, L., Al-Awqati, Q.: Segmental expression of Notch and Hairy genes in nephrogenesis. <i>Am J Physiol Renal Physiol<\/i>. <b>288<\/b>: F939-952, 2005."},{"key":"42","unstructured":"42) McCright, B., et al.: Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. <i>Development<\/i>. <b>128<\/b>: 491-502, 2001."},{"key":"43","unstructured":"43) McLaughlin, K.A., et al.: Notch regulates cell fate in the developing pronephros. <i>Dev Biol<\/i>. <b>227<\/b>: 567-580, 2000."},{"key":"44","unstructured":"44) Cheng, H.T., et al.: Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. <i>Development<\/i>. <b>134<\/b>: 801-811, 2007."},{"key":"45","unstructured":"45) Niranjan, T., et al.: The Notch pathway in podocytes plays a role in the development of glomerular disease. <i>Nat Med<\/i>. <b>14<\/b>: 290-298, 2008."},{"key":"46","unstructured":"46) Tanaka, E., et al.: Notch2 activation ameliorates nephrosis. <i>Nat Commun<\/i>. <b>5<\/b>: 3296, 2014."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":["\u6162\u6027\u814e\u81d3\u75c5\u306b\u304a\u3051\u308b\u30dd\u30c9\u30b5\u30a4\u30c8\u969c\u5bb3\u306e\u5f79\u5272"],"language":"en","deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T20:21:03Z","timestamp":1566418863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/38\/1\/38_26\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.38.26","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}